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Ghrelin plays a major role in obesity-related diseases which have been shown to be associated with periodontitis. This study sought
to analyze the expression of the functional receptor for ghrelin (GHS-R1a) in periodontal cells and tissues under microbial
conditions in vitro and in vivo. The GHS-R1a expression in human periodontal cells challenged with the periodontopathogen
Fusobacterium nucleatum, in gingival biopsies from periodontally healthy and diseased individuals, and from rats with and
without ligature-induced periodontitis was analyzed by real-time PCR, immunocytochemistry, and immunoﬂuorescence. F.
nucleatum induced an initial upregulation and subsequent downregulation of GHS-R1a in periodontal cells. In rat experimental
periodontitis, the GHS-R1a expression at periodontitis sites was increased during the early stage of periodontitis, but
signiﬁcantly reduced afterwards, when compared with healthy sites. In human gingival biopsies, periodontally diseased sites
showed a signiﬁcantly lower GHS-R1a expression than the healthy sites. The expression of the functional ghrelin receptor in
periodontal cells and tissues is modulated by periodontal bacteria. Due to the downregulation of the functional ghrelin receptor
by long-term exposure to periodontal bacteria, the anti-inﬂammatory actions of ghrelin may be diminished in chronic
periodontal infections, which could lead to an enhanced periodontal inﬂammation and tissue destruction.
1. Introduction
Periodontitis represents one of the most prevalent diseases
aﬀecting systemic health and the quality of life [1, 2]. It is
a multifactorial inﬂammatory disease elicited by a complex
of several bacterial species in the subgingival bioﬁlm, such
as Porphyromonas gingivalis, Tannerella forsythia, Trepo-
nema denticola, Aggregatibacter actinomycetemcomitans,
and Fusobacterium nucleatum. Smoking, genetic predisposi-
tion, mental stress, and several systemic diseases are also
important contributing factors to the initiation and progres-
sion of periodontitis [3]. The bacterial species interact with
inﬁltrating and resident host cells, thereby causing the release
of a broad array of inﬂammatory mediators and proteases,
such as interleukin- (IL-) 1β, IL-6, IL-8, tumor necrosis
factor-α (TNF), cyclooxygenase-2 (COX2), chemokine CC
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motif ligand 2 (CCL2), and matrix metalloproteinases
(MMPs) [4, 5]. If the immunoinﬂammatory response is
exaggerated and/or prolonged, irreversible destruction of
periodontal tissues including periodontal ligament (PDL)
and alveolar bone can occur, resulting in periodontal
pocket formation and even tooth loss.
A substantial body of studies has shown that periodonti-
tis is associated with the onset, development, and/or progres-
sion of systemic diseases, such as cardiovascular diseases,
type 2 diabetes, obesity, and metabolic syndrome [6–9].
However, the pathomechanisms underlying these associa-
tions are yet to be clariﬁed and require further investigation.
It is noteworthy that the role of ghrelin (GHRL) in periodon-
tal health and disease has become the focus of a few recent
studies due to its link to obesity as well as its modulatory
functions on the immune system [10, 11]. GHRL, which
was originally identiﬁed as a hormone secreted mainly by
gastrointestinal cells, plays a critical role in a range of biolog-
ical processes, such as regulating food intake, energy balance,
body weight as well as sleep, and memory [12–14]. GHRL
mediates its actions by binding to its receptor, the growth
hormone secretagogue receptor (GHS-R), which has been
found in the hypothalamus, pituitary, pancreas, heart, sali-
vary glands, stomach, and many other organs [15, 16].
GHS-R is expressed in two isoforms: type 1a and 1b. As a
G protein-coupled receptor, GHS-R1a consists of 366 amino
acids with the typical seven transmembrane domains. Upon
binding with GHRL, GHS-R1a undergoes a profound change
in conformation and triggers a diversity of physiological
responses, while the inactive GHS-R variant, the GHS-R1b,
does not mediate any eﬀects of GHRL [16]. Until now, only
a few studies have focused on the role of GHRL in periodon-
titis to explore whether GHRL may be involved in the regula-
tion of periodontal inﬂammatory responses. Brieﬂy, GHRL
levels in gingival crevicular ﬂuid (GCF) have been found
lower in periodontitis patients when compared with healthy
subjects [17]. However, this observation was in contrast
to the GHRL levels in serum [18]. GHRL was also detected
in saliva as well as in several cells and tissues of the tooth
germ, such as inner enamel epithelium, mesenchymal cells,
ameloblasts, odontoblasts, and Hertwig’s epithelial root
sheath [19–21]. Nevertheless, the exact role of the GHRL/
GHS-R system in periodontal health and disease is yet to
be unraveled. Therefore, the main objective of the present
study was to evaluate the expression of GHS-R1a in peri-
odontal cells and tissues under microbial conditions in vitro
and in vivo.
2. Materials and Methods
2.1. Human PDL Cell Culture and Treatment. This study and
the protocols were approved by the Ethics Committee of the
University of Bonn, and written informed consent was
obtained prior to sample collection (number 043/11).
Human PDL cells were isolated from periodontally healthy
teeth that were extracted for orthodontic indications. Brieﬂy,
the cells were cultured in Dulbecco’s minimal essential
medium (DMEM, Invitrogen, Karlsruhe, Germany) supple-
mented with 10% fetal bovine serum (FBS, Invitrogen),
100U/mL penicillin, and 100 μg/mL streptomycin (Invi-
trogen) at 37°C in a humidiﬁed atmosphere of 5% CO2.
Cells between the 3rd passage and the 5th passage were
seeded (5.0× 104 cells/well) on culture plates and grown
to 80% conﬂuence. One day prior to the experiments,
the FBS concentration was reduced to 1%. The medium
was changed every second day.
To mimic oral infections by microbial pathogens
in vitro, oral pathogenic bacteria associated with periodon-
titis were selected and applied to challenge the PDL cells
for up to 2 d: F. nucleatum ATCC 25586 (OD660: 0.025,
0.05, 0.1, and 0.2), P. gingivalis ATCC 33277 (OD660:
0.05, 0.1 and 0.2), A. actinomycetemcomitans Y4 (OD660:
0.1), and T. denticola (OD660: 0.1). Bacteria were sus-
pended in phosphate-buﬀered saline (PBS) (OD660 = 1.0,
equivalent to 1.2× 109 bacterial cells/mL) and subjected twice
to ultrasonication (160W for 15min). To evaluate the possi-
ble anti-inﬂammatory actions of the GHRL/GHS-R system,
PDL cells were preincubated with 20 nM of GHRL (human
n-octanoylated ghrelin, Pepta Nova, Sandhausen, Germany)
and 10 μg/mL of Toll-like receptor-4 (TLR4) blocking anti-
body (eBioscience, San Diego, CA, USA), respectively,
45min prior to the challenge with F. nucleatum.
2.2. Human Gingival Biopsies. Human gingiva samples were
obtained from 10 patients with periodontitis from the
Department of Oral Surgery of the University of Bonn during
tooth extraction for periodontal indications. Written
informed consent and approval of the Ethics Committee of
the University of Bonn were obtained (number 043/11).
Samples collected from 10 individuals with gingivitis and
10 periodontally healthy donors during wisdom tooth
removal or tooth extraction for orthodontic indications were
also used [22]. Participants diagnosed with systemic diseases
or having smoking habits were excluded. Clinically, gingival
index (GI), probing pocket depth (PD), clinical attachment
loss (CAL), and radiographic bone loss were assessed. Gingi-
val sites with GI= 0 (no clinical inﬂammation), PD≤ 3mm,
no CAL, and no radiographic bone loss were deﬁned as peri-
odontally healthy, and the sites with GI> 1, PD≥ 5mm,
CAL≥ 3mm, and radiographic bone loss were deﬁned as
having periodontal disease.
2.3. Rat Gingival Biopsies. All animal experimental proce-
dures described in this study were approved by the Ethical
Committee on Animal Experimentation at the School of
Dentistry at Araraquara, São Paulo State University
(UNESP) (protocol number 23/2012), in compliance with
the Animal Research: Reporting of In Vivo Experiments
(ARRIVE) guidelines. A total of 24 male adult Holtzman rats
weighing about 300 g were selected and caged in an animal
house with provision of standard laboratory food and water
ad libitum. Experimental periodontitis in rats was induced
by using ligatures, as previously described [23]. Brieﬂy, the
animals were randomly divided into two groups. One group
was left untreated and served as the control, and the other
group was subjected to ligation to induce periodontal disease.
A cotton ligature was tied around the cervical area of the
maxillary ﬁrst molars bilaterally. The knot was placed
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mesially under anesthesia with intramuscular injections of
ketamine chlorhydrate 10% (0.08mL/100 g body weight)
and xylazine chlorhydrate 2% (0.04mL/100 g body weight).
At three diﬀerent time points following ligation (6 d, 8 d,
and 12d), 4 rats from each group were sacriﬁced and
the gingival tissues around the maxillary ﬁrst molars were
carefully dissected for total RNA extraction followed by
real-time PCR.
2.4. Real-Time Polymerase Chain Reaction. The gene expres-
sions in samples from PDL cells as well as human and rat gin-
gival biopsies were analyzed by quantitative RT-PCR. Total
RNA extraction was performed using an RNeasy Mini Kit
(Qiagen, Hilden, Germany) according to the manufacturer’s
protocol. RNA concentration was determined by a Nano-
Drop ND-2000 (Thermo Fisher Scientiﬁc, Wilmington, DE,
USA) spectrophotometer, and 500 ng of total RNA was
reversely transcribed using the iScript™ Select cDNA Syn-
thesis Kit (Bio-Rad Laboratories, Munich, Germany) at
42°C for 90min followed by 85°C for 5min as per the
manufacturer’s instruction. The analysis of gene expres-
sions of GHS-R1a, CCL2, IL-6, and IL-8 was subsequently
performed in triplicate by using QuantiTect Primers (Qia-
gen), SYBR Green QPCR Master Mix (Bio-Rad), and the
iCycler iQ™ Real-Time PCR Detection System (Bio-Rad).
Ampliﬁcation was carried out under the following condi-
tions: initial denaturation at 95°C for 5min and followed
by 40 cycles of denaturation at 95°C for 10 s and com-
bined annealing/extension at 60°C for 30 s. Data were ana-
lyzed using the comparative threshold cycle (CT) method
with glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
as the housekeeping gene.
2.5. Immunocytochemistry for GHS-R Detection. PDL cells
were grown in the presence or absence of F. nucleatum on
plastic coverslips (Thermo Fisher Scientiﬁc) of 13mm diam-
eter in 24-well plates for 1 d and 2d. Cell monolayers were
ﬁxed in 4% paraformaldehyde (Sigma-Aldrich, Munich,
Germany) at pH7.4 and room temperature (RT) for 10min
and permeabilized in 0.1% Triton X-100 (Sigma-Aldrich)
for 5min followed by blocking using serum block (Dako,
Hamburg, Germany) for 20min. Afterwards, the cells were
labeled with rabbit polyclonal primary antibody to GHS-R
(Abcam, Cambridge, UK, 1 : 500) in a humid chamber at
4°C overnight and then incubated with goat anti-rabbit IgG
HRP secondary antibody (Dako) for 45min. The cells were
rinsed with PBS (Invitrogen) in between each step. Finally,
the cells were mounted with DePeX (SERVA Electrophoresis,
Heidelberg, Germany) and the production of GHS-R was
assessed with an Axioskop 2 microscope (20×, Carl Zeiss,
Germany). The images were captured with an AxioCam
MRc camera and analyzed with the AxioVision 4.7 software
(Carl Zeiss). Untreated cells were used as a control.
2.6. Immunoﬂuorescence for Nuclear Factor-κB p65
Detection. Plastic coverslips (Thermo Fisher Scientiﬁc) with
growing PDL cells were incubated in the presence or absence
of F. nucleatum for 90min. Following the immunocytochem-
istry method as described above, the cells were ﬁxed and
permeabilized and then blocked with nonfat dry milk
(Bio-Rad) for 1 h. The slides were subsequently incubated
with a rabbit anti-nuclear factor-κB p65 (E498) primary
antibody (Cell Signaling Technology, Danvers, MA, USA;
1 : 100) for 90min at RT. After rinsing with PBS and incubat-
ing with CY3-conjugated goat anti-rabbit IgG secondary
antibody (Abcam; 1 : 1000) for 45min at RT, the expression
of NF-κB p65 in cells was observed with the ZOE™ Fluores-
cent Cell Imager (Bio-Rad) with a 20x objective. The images
were captured with an integrated digital 5MP CMOS camera.
Untreated cells were used as a control.
2.7. Immunohistochemistry for GHS-R Detection. Human
gingival biopsies from healthy donors and periodontitis
patients (n = 3) were ﬁrst ﬁxed in 4% paraformaldehyde
(Sigma-Aldrich) for 2 d, dehydrated in an ascending ethanol
series (AppliChem, Darmstadt, Germany), and subsequently
embedded in paraﬃn (McCormick Scientiﬁc, Richmond, IL,
USA). The samples in paraﬃn were sectioned at 2.5 μm
thickness, mounted onto glass slides (Carl Roth, Karlsruhe,
Germany), and dried at 37°C overnight. First, sections with
healthy and inﬂamed gingival tissues were stained with
hematoxylin and eosin (H&E; Merck Eurolab, Darmstadt,
Germany). Next, after deparaﬃnization and rehydration,
selected sections were rinsed in PBS for 2min. Subsequently,
endogenous peroxidase was blocked using 0.3% methanol
(AppliChem)/H2O2 (Merck Eurolab) solution for 5min.
Next, the sections were blocked with goat serum (Dako) for
20min and incubated with rabbit primary polyclonal GHS-
R antibody (Abcam; 1 : 100) in a humid chamber at 4°C over-
night. Then, the sections were washed with PBS and incu-
bated with goat anti-rabbit IgG-HRP secondary antibody
(Dako) at RT for 30min. The peroxidase activity was visual-
ized with DAB chromogen (Thermo Fisher Scientiﬁc).
Finally, all slides were rinsed with PBS and counterstained
with Mayer’s hematoxylin (Merck Eurolab) for 1min. The
images were collected using an Axioskop 2 microscope and
analyzed with the AxioVision 4.7 software.
2.8. Statistical Analysis. The IBM SPSS Statistics software
(Version 22, IBM SPSS, Chicago, IL, USA) was used for
statistical analysis. Mean values and standard errors of the
mean (SEM) were calculated for quantitative data. All exper-
iments were performed in triplicate and repeated at least
twice. For statistical comparison of the groups, the t-test,
Mann–Whitney U test, and ANOVA followed by the post
hoc Dunnett test were applied. Diﬀerences between groups
were considered signiﬁcant at p < 0 05.
3. Results
3.1. Regulation of GHS-R1a by F. nucleatum in Human PDL
Cells. First, we studied in vitro if GHS-R1a is expressed in
PDL cells and, if so, whether this expression is regulated by
the periodontopathogen F. nucleatum. Our experiments
revealed that GHS-R1a was constitutively expressed in
PDL cells and signiﬁcantly upregulated by stimulation
with F. nucleatum for 1 d. However, incubation of cells
with F. nucleatum for a longer time, that is, 2 d, resulted
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in a remarkable downregulation of the receptor expression,
as shown in Figure 1(a). Further experiments demonstrated
that the short-term stimulatory eﬀect of F. nucleatum on
the GHS-R1a expression was dose-dependent, with the high-
est GHS-R1a expression levels at an OD660 of 0.1 at 1 d
(Figure 1(b)). The stimulatory eﬀect of F. nucleatum on
GHS-R was also observed at protein level, as analyzed by
immunocytochemistry. As depicted in Figure 1(c), higher
GHS-R protein levels were found in F. nucleatum-stimulated
cells as compared with the control. Notably, other periodon-
tal pathogens were also capable of increasing the GHS-R1a
expression in PDL cells. Incubation of cells with P. gingivalis,
T. denticola, and A. actinomycetemcomitans Y4 (OD660 = 0.1)
increased signiﬁcantly the GHS-R1a expression in PDL cells
at 1 d (Figure 1(d)).
In another set of experiments, we sought to unravel
the mechanisms underlying the stimulatory eﬀect of F.
nucleatum on GHS-R1a expression. As expected, F. nucle-
atum activated the NF-κB signaling pathway and caused a
maximal NF-κB nuclear translocation at 60min, as analyzed
by immunoﬂuorescence microscopy (Figure 2(a)). As our
previous studies had demonstrated that F. nucleatum acti-
vates TLRs, which trigger the NF-κB signaling pathway, we
analyzed if the actions of F. nucleatum on GHS-R1a would
also be dependent on TLRs [24]. When cells were preincu-
bated with an anti-TLR4 blocking antibody, the stimulatory
eﬀect of F. nucleatum was almost completely abolished at
1 d, as shown in Figure 2(b).
3.2. Eﬀects of GHRL on the Expressions of Cytokines and
GHS-R1a in PDL Cells. Next, we sought to prove a possible
anti-inﬂammatory nature of the GHRL/GHS-R system in
PDL. Stimulation of PDL cells with F. nucleatum increased
signiﬁcantly the expressions of CCL2, IL-6, and IL-8 at 1 d,
as expected. However, preincubation of the cells with
GHRL counteracted signiﬁcantly the stimulatory eﬀects of
F. nucleatum on the expressions of these proinﬂammatory/
chemotactic cytokines, as depicted in Figures 3(a)–3(c).
In the absence of F. nucleatum, no signiﬁcant eﬀects
of GHRL on the cytokine expressions were observed
(Figures 3(a)–3(c)). Interestingly, incubation of cells with
GHRL increased signiﬁcantly the expression of its own
functional receptor at 1 d (Figure 3(d)).
3.3. Expression of GHS-R1a in Gingival Biopsies from Human
and Rats. To study the expression and regulation of GHS-
R1a under microbial conditions in a more complex environ-
ment, human gingival biopsies from periodontally healthy,
gingivitis and periodontitis sites were collected and analyzed
for the synthesis of GHS-R1a. As analyzed by real-time PCR,
the GHS-R1a expression was signiﬁcantly downregulated in
gingival tissues from sites of periodontitis as compared with
periodontally healthy sites. A reduced GHS-R1a expression
was also found in gingival biopsies from gingivitis sites, even
though the diﬀerence, as compared with periodontally
healthy sites, did not reach signiﬁcance (Figure 4(a)). The
ﬁndings at transcriptional level were paralleled by observa-
tions at protein level. As revealed by immunohistochemistry,
staining against GHS-R protein was more pronounced and
frequently found in gingival biopsy samples collected
from healthy sites, when compared with sites of peri-
odontitis (Figure 4(b)). As GHS-R-positive cells, gingival
ﬁbroblasts of the lamina propria and gingival epithelial
cells were identiﬁed.
Finally, we also sought to study the time course of GHS-
R1a expression in a rat ligature-induced experimental peri-
odontitis model. As shown in Figure 4(c), the GHS-R1a
expression was higher at periodontitis sites than at healthy
control sites at 6 d and 8d, but the diﬀerences did not reach
statistical signiﬁcance. By contrast, gingival biopsies from sites
of periodontitis showed signiﬁcantly lower GHS-R1a levels,
when compared with control sites, at 12 d (Figure 4(c)).
4. Discussion
Our in vitro and in vivo experiments provide original evi-
dence that the expression of the functional ghrelin recep-
tor in periodontal cells and tissues is modulated by
periodontitis-associated microorganisms. Although GHS-
R1a was initially upregulated, a continuous exposure of
periodontal cells and tissues to periodontopathogens
resulted in a GHS-R1a downregulation. Our experiments
also demonstrated that GHRL inhibits the bacteria-induced
upregulation of proinﬂammatory and chemotactic cytokines,
thereby proving the anti-inﬂammatory nature of this peptide
hormone. These ﬁndings therefore suggest that, due to the
downregulation of the GHS-R1a by long-term exposure to
periodontal bacteria, the anti-inﬂammatory actions of
GHRL may be reduced in chronic periodontal infections,
which could lead to an enhanced periodontal inﬂammation
and destruction.
GHRL plays a critical role in a wide range of biological
processes, such as the regulation of food intake, energy
expenditure, body weight, sleep, and memory [12]. GHRL
mediates its eﬀects by binding to its functional receptor, that
is, GHS-R1a [15]. Until now, very little is known about the
physiology of the GHRL/GHS-R system in oral tissues.
GHRL and its receptors have been detected in submandibu-
lar, parotid, and sublingual salivary glands as well as in oral
epithelial cells and ﬁbroblasts [21, 25, 26]. Moreover, GHRL
can be found in saliva and GCF [17, 26]. Interestingly, GHRL
levels in GCF from patients with chronic periodontitis were
lower than those from healthy individuals. However, oppo-
site ﬁndings were reported, when periodontally healthy and
periodontitis subjects were also aﬄicted with type 2 diabetes
[17]. Another study has shown elevated plasma levels of
GHRL in patients with chronic periodontitis, as compared
with periodontally healthy individuals [18]. The aforemen-
tioned studies point strongly at a potential role of the
GHRL/GHS-R system in oral tissues.
Our in vitro experiments revealed that F. nucleatum
upregulated the CCL2, IL-6, and IL-8 expressions. These
cytokines exert proinﬂammatory and chemotactic eﬀects
and have been shown to be increased at sites of periodontitis
as compared with periodontally healthy sites [27, 28]. Our
ﬁndings concur with observations by other investigators
who have shown increased cytokine productions by
neutrophil-like cells and macrophages in response to F.
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Figure 1: (a) Expression of GHS-R1a in the presence and absence of F. nucleatum (Fn; OD660: 0.1) in PDL cells at 1 d and 2 d, as analyzed by
real-time PCR. Mean± SEM (n = 9). ∗Signiﬁcant (p < 0 05) diﬀerence between groups. (b) Expression of GHS-R1a in PDL cells exposed to
various concentrations of F. nucleatum (Fn; OD660: 0.05, 0.1, and 0.2) at 1 d. Nonstimulated cells served as control. Mean± SEM (n = 3).
(c) GHS-R protein synthesis in PDL cells stimulated with F. nucleatum (OD660: 0.1) for 1 d, as visualized by immunocytochemistry.
Nonstimulated cells served as control. Representative images from one out of three experiments are shown. (d) Expression of GHS-R1a in
PDL cells exposed to P. gingivalis (Pg), T. denticola (Td), or A. actinomycetemcomitans Y4 (Aa) (all OD660: 0.1) at 1 d, as determined by
real-time PCR. Unstimulated cells served as control. Mean± SEM (n = 24). ∗Signiﬁcantly (p < 0 05) diﬀerent from control.
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Figure 2: (a) Stimulation of NF-κB (p65) nuclear translocation by F. nucleatum (OD660: 0.1) in PDL cells over 60min, as analyzed by
immunoﬂuorescence microscopy. Representative images from one out of three experiments are shown. (b) Expression of GHS-R1a in
PDL cells stimulated with F. nucleatum (Fn; OD660: 0.1) in the presence and absence of anti-TLR4 blocking antibody at 1 d, as determined
by real-time PCR. Mean± SEM (n = 3). ∗Signiﬁcant (p < 0 05) diﬀerence between groups.
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Figure 3: Expressions of CCL2 (a), IL-6 (b), and IL-8 (c) in PDL cells in the presence of F. nucleatum (Fn; OD660: 0.1) and/or GHRL (20 nM)
at 1 d, as analyzed by real-time PCR. Unstimulated cells served as control. Mean± SEM (n = 15). ∗Signiﬁcant (p < 0 05) diﬀerence between
groups. (d) Expression of GHS-R1a in PDL cells in the presence and absence of GHRL (20 nM) at 1 d. Mean± SEM (n = 12). ∗Signiﬁcant
(p < 0 05) diﬀerence between groups.
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nucleatum [29, 30]. Notably, GHRL inhibited the F. nuclea-
tum-induced upregulation of these cytokines in periodontal
cells, thereby proving the anti-inﬂammatory nature of this
peptide hormone. The ﬁnding that GHRL can cause a down-
regulation of stimulated cytokine expressions has also been
observed in other cells and species. For example, it has been
shown that GHRL counteracts the stimulatory eﬀects of lipo-
polysaccharide (LPS) on the IL-6 and IL-8 releases from
mouse dopaminergic neurons and human oral epithelial
cells, respectively [26, 31]. Similarly, GHRL inhibited the
endotoxin-induced IL-8, TNFα, and CCL2 syntheses in rats
[32]. In addition, GHRL abolished the stimulatory actions
of TNFα and angiotensin II on the cytokine production by
human umbilical vein endothelial cells [32, 33]. Interestingly,
the anti-inﬂammatory actions of GHRL seem to involve the
NF-κB pathway [33, 34]. The studies mentioned above
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Figure 4: (a) GHS-R1a expression in human gingival biopsies from periodontally healthy (H), gingivitis (G), and periodontitis (P) sites, as
analyzed by real-time PCR. Mean± SEM (n = 10 donors/group). ∗Signiﬁcant (p < 0 05) diﬀerence between groups. (b) GHS-R protein
immunostaining in human gingival biopsies from periodontally healthy control and periodontitis sites, as visualized by
immunohistochemistry. Representative images from one out of three donors of each group are shown. LP: lamina propria; GE: gingival
epithelium. (c) GHS-R1a expression in rat gingival biopsies from periodontally healthy (C) and periodontitis (P) sites at 6 d, 8 d, and 12 d,
as analyzed by real-time PCR. Mean± SEM (n = 4 rats/group). ∗Signiﬁcant (p < 0 05) diﬀerence between groups.
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support our ﬁndings which suggest that GHRL may play
an important role in controlling periodontal inﬂammation.
In the present in vitro study, F. nucleatum was used to
mimic an infectious environment, as in our previous experi-
ments [24, 35]. F. nucleatum represents a gram-negative,
anaerobic microorganism which functions as a bridge bac-
terium between early and late colonizers during bioﬁlm
development. It is associated with both gingivitis and peri-
odontitis, invades periodontal cells, and supports other peri-
odontal bacteria to invade host cells [36–38]. Periodontitis is
a mixed polymicrobial disease, and other bacterial species are
involved. Interestingly, the periodontitis-associated bacteria
P. gingivalis, T. denticola, and A. actinomycetemcomitans also
caused an upregulation of the GHS-R1a. Nevertheless,
further studies are necessary to analyze the eﬀects of a mixed
bacterial bioﬁlm on the GHRL/GHS-R system. Moreover, the
bacteria used in our experiments were lysed and, therefore,
nonvital. Although LPS might have been a major compound
of this lysate, other virulence factors may also have contrib-
uted to the stimulatory eﬀects of the bacteria used in our
experiments, which should be investigated in further studies.
Since the Toll-like receptor- (TLR-) NF-κB pathway is
involved in the expression of proinﬂammatory cytokines,
we also studied the eﬀects of F. nucleatum on this signaling
pathway in PDL cells. F. nucleatum stimulated the nuclear
translocation of NF-κB in PDL cells, which is consistent with
previous reports [24]. Studies in neutrophil-like cells,
colorectal cancer cells, and macrophages have also shown
that F. nucleatum exploits this pathway for its eﬀects on the
production of cytokines, thereby supporting our observation
[29, 30, 39]. Since the NF-κB pathway can be activated by
TLR4, we next preincubated PDL cells with an anti-TLR4
blocking antibody. Our experiments showed that the initial
stimulatory eﬀect of F. nucleatum on the GHS-R1a expres-
sion was indeed dependent on TLR4. Whether additional
pathways are involved in the actions of F. nucleatum on the
GHRL/GHS-R system should be unraveled in future studies.
To investigate the GHS-R1a expression in periodontal
cells in a more complex environment, gingival biopsies from
periodontitis patients and periodontally healthy individuals
were analyzed [22]. The weakest GHS-R1a expression was
found in biopsies from subjects with periodontitis. The
GHS-R1a expression in gingival tissues from gingivitis
subjects was also lower than that from periodontally healthy
subjects, but higher than that from periodontitis patients.
These ﬁndings show clearly a dose-dependent GHS-R1a
downregulation in gingival tissues. Furthermore, as analyzed
by immunohistochemistry, the GHS-R protein was also
reduced in gingiva from periodontitis patients, which paral-
leled our ﬁndings at transcriptional level. Moreover, the his-
tological analyses revealed that the GHS-R1 is not only
produced by ﬁbroblasts but also by epithelial cells. To moni-
tor the GHS-R1a expression in periodontal cells and tissues
under bacterial condition over time, a rat ligature-induced
periodontitis model was applied. The ligature-induced
plaque accumulation led to a signiﬁcant periodontal inﬂam-
mation and tissue destruction [23]. In this in vivo model,
the GHS-R1a expression in gingival samples was initially
upregulated, which is in accordance with our in vitro data.
However, chronic exposure of the periodontal tissues to the
ligature-induced plaque accumulation caused a signiﬁcant
downregulation of GHS-R1a, conﬁrming our ﬁndings from
human gingival biopsies. These in vivo data conﬁrm and
expand our in vitro results, demonstrating that a long-term
incubation of periodontal cells and tissues with periodontal
bacteria causes a downregulation of the functional receptor
for the anti-inﬂammatory peptide GHRL.
In the in vitro experiments, PDL cells were used, as they
play a critical role in periodontal destruction and regenera-
tion. The PDL cells had been phenotyped prior to their use
to conﬁrm their ability to diﬀerentiate in osteoblastic cells.
Since no osteogenic medium was used in the present
in vitro experiments, these cells attained a ﬁbroblastic pheno-
type, which facilitated the comparison with the gingival
tissue samples from human and rats.
5. Conclusions
Our study provides novel evidence that the GHS-R1a expres-
sion in periodontal cells is modulated by periodontitis-
associated microorganisms. Despite an initial GHS-R1a
upregulation, which may serve as a protective cellular
response, a continuous exposure of periodontal cells to peri-
odontopathogens results in a GHS-R1a downregulation. Our
experiments also demonstrated that GHRL inhibits the
bacteria-induced expression of proinﬂammatory cytokines
in periodontal cells. Therefore, due to the downregulation
of the functional ghrelin receptor, the anti-inﬂammatory
actions of GHRL may be diminished in chronic periodontal
infections, which could lead to an enhanced periodontal
inﬂammation and tissue destruction.
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